Sonnet BioTherapeutics I... (SONN)
undefined
undefined%
At close: undefined
1.85
-2.89%
Pre-market Jan 07, 2025, 05:52 AM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07
Cash & Equivalents 149.46K 2.27M 3.05M 27.62M 7.35M 35.65K 524.11K 438.49K 268.57K 1.53M n/a 442.69K 1.25M 151.93K 46.01M 2.37K 14.15K n/a
Short-Term Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments n/a n/a n/a n/a n/a 800.00K 800.00K 800.00K 800.00K 31.32K n/a 55.11K 56.95K 318.35K 352.50M 83.29K 108.55K n/a
Other Long-Term Assets 509.15K 464.19K 113.28K -182.27K 82.96K 446.64K 2.86M 490.33K 442.74K 1.73M n/a 2.78M 2.29M 1.58M 877.78M 1.28M 2.06M n/a
Receivables n/a 786.57K n/a n/a n/a n/a 325.36K 475.99K 524.48K 862.93K n/a 393.87K 384.31K 180.57K 4.26M n/a n/a 18.90K
Inventory n/a n/a -717.30K n/a n/a 478.31K 335.21K 460.76K 539.55K 726.62K n/a 381.41K 227.02K 59.27K n/a n/a n/a n/a
Other Current Assets 1.97M 1.68M 4.00M 2.38M 575.48K 4.10K 490.46K 424.32K 461.07K 1.16M n/a 495.17K 170.77K 231.91K 108.48M 57.81K 9.40K n/a
Total Current Assets 2.12M 4.74M 5.41M 28.81M 7.64M 39.75K 1.34M 1.80M 1.79M 3.82M n/a 1.71M 2.03M 623.68K 158.72M 60.18K 23.56K 18.90K
Property-Plant & Equipment 143.94K 227.06K 302.81K 182.27K 273.81K 10.47M 9.76M 8.55M 11.51M 16.64M n/a 5.62M 2.32M 2.51M 25.56M 32.13K 36.16K 45.54K
Goodwill & Intangibles n/a n/a n/a n/a n/a 16.40M 25.60M 31.19M 31.34M 19.98M n/a 9.92M 956.32K 470.16K n/a n/a n/a n/a
Total Long-Term Assets 653.09K 691.25K 416.08K 182.27K 356.77K 28.12M 28.45M 28.38M 31.69M 38.39M n/a 18.37M 5.62M 4.88M 1.26B 1.39M 2.20M 45.54K
Total Assets 2.77M 5.43M 5.83M 28.99M 7.99M 39.75K 29.79M 30.18M 33.49M 42.21M n/a 20.09M 7.65M 5.50M 1.41B 1.45M 2.23M 3.82M
Account Payables 2.18M 2.20M 4.75M 3.78M 2.06M 1.84M 2.38M 3.68M 3.81M n/a n/a 2.42M 737.01K 267.48K 211.43M 190.48K 178.32K 25.55K
Deferred Revenue n/a 18.63K 166.43K 516.37K 500.00K 1.17M 1.17M 83.88K 173.78K n/a n/a n/a n/a 14.61K 1.75M 20.83K n/a 128.56K
Short-Term Debt 84.29K 73.05K 52.08K 95.27K 103.24K 217.38K 9.24M 8.74M 6.38M 8.23M n/a 759.33K 264.07K 2.83M 250.00M 412.50K 500.00K 165.27K
Other Current Liabilities 942.49K 3.23M 3.19M 2.31M 2.06M 826.77K 4.03M 2.40M 1.67M 7.95M n/a 2.29M 760.94K 518.16K 182.45M n/a n/a n/a
Total Current Liabilities 3.21M 5.52M 8.16M 6.70M 4.72M 2.89M 13.03M 14.73M 12.11M 16.18M n/a 5.53M 1.77M 3.63M 645.63M 623.82K 678.33K 319.38K
Long-Term Debt 46.57K 130.86K 203.91K 30.61K 250.01K n/a 3.67M 677.39K 3.97M 1.11M n/a 105.92K 60.52K 236.11K 686.50M n/a n/a n/a
Other Long-Term Liabilities n/a n/a n/a n/a n/a -102.30K 3.58M 2.16M 1.96M 1.80M n/a 815.57K 186.06K n/a n/a 111.84K 7.80K 29.89K
Total Long-Term Liabilities 46.57K 130.86K 203.91K 30.61K 250.01K 7.22M 8.51M 3.96M 7.41M 4.27M n/a 3.32M 345.03K 236.11K 686.50M 111.84K 7.80K 29.89K
Total Liabilities 3.26M 5.66M 8.37M 6.73M 4.97M 2.89M 21.54M 18.69M 19.52M 20.45M n/a 8.85M 2.12M 3.86M 1.33B 735.65K 686.13K 349.27K
Total Debt 130.86K 203.91K 255.99K 125.88K 353.25K 217.38K 10.34M 9.59M 10.35M 9.33M n/a 1.35M 264.07K 3.03M 936.50M 412.50K 500.00K 165.27K
Common Stock 65.00 175.00 554.00 6.03K 1.47K 555.00 373.00 305.00 2.14K 2.13K n/a 541.00 370.00 301.00 257.00K n/a n/a 833.00
Retained Earnings -117.68M -110.24M -91.41M -61.69M -36.71M -12.44M -57.12M -49.11M -42.21M -33.01M n/a -14.47M -9.26M -6.03M -4.93B -3.92M -1.95M n/a
Comprehensive Income n/a -0.00 n/a n/a n/a -202.12K -202.12K -934.90K -1.16M -987.70K n/a n/a n/a n/a n/a n/a -1.15M n/a
Shareholders Equity -485.74K -225.98K -2.54M 22.26M 3.02M -2.85M 7.43M 10.71M 12.82M 21.76M n/a 11.24M 5.53M 1.64M 82.42M 718.02K 1.54M 3.48M
Total Investments n/a n/a n/a n/a n/a 800.00K 800.00K 800.00K 800.00K 31.32K n/a 55.11K 56.95K 318.35K 352.50M 83.29K 108.55K 3.74M